This guideline has been approved by the AASLD and represents the position of the association.
Anticentromere antibodies in primary biliary cirrhosis
โ Scribed by Drew Makinen; Marvin Fritzler; Dr Paul Davis; Sheila Sherlock
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 371 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In our previous work, including analysis of more than 10,000 sera from control patients and patients with a variety of liver diseases, we have demonstrated that with the use of recombinant autoantigens, antimitochondrial autoantibodies (AMAs) are only found in primary biliary cirrhosis (PBC) and tha
We read with interest the article by Nakamura et al. 1 reporting clinical and prognostic significance of autoantibodies to nuclear pore gp210 antigen and centromere in primary biliary cirrhosis (PBC). By studying 276 Japanese patients, the authors found that anti-gp210 antibody positivity was a risk
## Anti -mitochondrial antibodies (AMAs) have long been recognized as a serological hallmark of primary biliary cirrhosis (PBC). Although high titers of immunoglobulin (Ig)A AMAs are found in bile, saliva, and urine of patients, a pathogenic role for this antibody has remained elusive. Functional